Back to results
US 4,377,583 AGranted
N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-c arboxylic acid
AssigneeMead Johnson & Company
InventorsAubrey A. Larsen, Donald A. Owens
Life of this patent
Estimating the term…
Abstract
Treatment of the antiallergic agent 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-car boxylic acid with N-methyl-D-glucamine gives a salt with improved solubility. Solutions of this salt have pH values in a range acceptable for topical formulations. Additionally, solutions of the subject salt exhibit good stability which can be demonstrated by retention of potency. The salt is comprised of a 1:1 molecular ratio of the glucamine base to the acid.
Claims4
The N-methyl-D-glucamine salt of 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothienyl[2,3-d]pyrimidine-2-ca rboxylic acid.
Dependencies are inferred from the claim text.